Voyager Provides Update on SOD1 ALS Gene Therapy Program
Company to assess alternate payloads; no changes planned to novel capsid component - - Resulting shift of timeline and costs extends cash ...
Arvinas Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Announced that topline data from the monotherapy Phase 3 VERITAC-2 trial isanticipated in 1Q25 –– Presented Phase 1b data from the TACTIVE-U ...
Arsenal F.C.1d
Mark Antoniewicz: PL Community Captain
Mark Antoniewicz, known as AZ, has been named our Premier League Community Captain, in recognition of his dedication, ...
The Vivienne to be honoured by RuPaul’s Drag Race stars at first-ever Metro Pride Awards
RuPaul’s Drag Race UK favourites Tia Kofi, Baga Chipz, Danny Beard, Cheryl the Queen, and Michael Marouli will take to the ...
Scientists Deplore Sharp US Cut In Medical Research Funding
The National Institutes of Health (NIH) said late Friday it was setting a 15 percent limit on its funding of "indirect," or ...
News Medical4d
Researchers discover strategy to slow brain metastases growth in melanoma
Brain metastases are one of the most severe complications of melanoma, the most aggressive type of skin cancer. Researchers ...
A CHOP researcher and the NFL studied 5,100 player collisions. Here’s what they found.
For four seasons, 98 NFL players volunteered mouth guard sensors that recorded data about their head movements. Their ...
Original Black Sabbath lineup to play for 1st time in 20 years as part of Ozzy Osbourne’s last show
One of the most legendary heavy metal bands of all time is reuniting.
Ozzy Osbourne to reunite with Black Sabbath bandmates in Birmingham for 'greatest' show ever
Ozzy Osbourne will reunite with all of the original members of Black Sabbath for the first time in 20 years, in a gig that ...
Sharon Osbourne says ‘it’s time for Ozzy Osbourne to say good night’ with final gig
Black Sabbath have announced their final ever show with vocalist Ozzy Osbourne will take place this summer, marking the first ...
Newronika Receives Investigational Device Exemption (IDE) from FDA to Initiate U.S. Clinical Trial of Adaptive DBS System
Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an ...
News Medical6d
GLP-1 drug exenatide shows no benefit for Parkinson's in new study
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.